Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zai Lab (shanghai) Co., Ltd.

Clinical trials sponsored by Zai Lab (shanghai) Co., Ltd., explained in plain language.

Zai Lab (Shanghai) Co., Ltd. ZLAB NASDAQ

A commercial-stage biopharmaceutical company developing and commercializing innovative medicines.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 6 Not yet recruiting 1 Completed 1

New targeted drug takes on stomach cancer in Head-to-Head trial

Disease control Completed

This phase 2 trial compares two oral targeted drugs—ripretinib and sunitinib—in 108 people with advanced gastrointestinal stromal tumors (GIST) whose cancer has worsened on or who cannot tolerate imatinib. The main goal is to see which drug better delays cancer growth. Participan…

Phase: PHASE2 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC